Timothy W. Morris

Monitoring Antibiotic Resistance in Ocular Microorganisms: Results From the Antibiotic Resistance Monitoring in Ocular MicRorganisms (ARMOR) 2009 Surveillance Study

Wolfgang Haas, Chris M. Pillar, Mohana Torres et al. · American Journal of Ophthalmology · 2011 · 154 citations

Antimicrobial Resistance Gene, Antimicrobial Susceptibility, Health Sciences +12

Antibiotic Resistance Among Ocular Pathogens in the United States

Penny A. Asbell, Christine M. Sanfilippo, Christopher M. Pillar et al. · JAMA Ophthalmology · 2015 · 152 citations

Purification and properties of the lipoate protein ligase of <i>Escherichia coli</i>

D.E. Green, Timothy W. Morris, J Green et al. · Biochemical Journal · 1995 · 120 citations · Full text

Besifloxacin, a Novel Fluoroquinolone, Has Broad-Spectrum In Vitro Activity against Aerobic and Anaerobic Bacteria

Wolfgang Haas, Chris M. Pillar, Gary E. Zurenko et al. · Antimicrobial Agents and Chemotherapy · 2009 · 102 citations · Full text

Antibacterial Spectrum, Health Sciences, Antibiotics +15

Efficacy and Safety of Besifloxacin Ophthalmic Suspension 0.6% Compared with Moxifloxacin Ophthalmic Solution 0.5% for Treating Bacterial Conjunctivitis

Marguerite B. McDonald, Eugene Protzko, Lynne S. Brunner et al. · Ophthalmology · 2009 · 80 citations

Ocular Disease, Ophthalmology, Eye Health +7